PL3145490T3 - Liposomy zawierające kwas dihomo-gamma-linolenowy (dgla), zawierające je preparaty i ich zastosowanie - Google Patents

Liposomy zawierające kwas dihomo-gamma-linolenowy (dgla), zawierające je preparaty i ich zastosowanie

Info

Publication number
PL3145490T3
PL3145490T3 PL15728175T PL15728175T PL3145490T3 PL 3145490 T3 PL3145490 T3 PL 3145490T3 PL 15728175 T PL15728175 T PL 15728175T PL 15728175 T PL15728175 T PL 15728175T PL 3145490 T3 PL3145490 T3 PL 3145490T3
Authority
PL
Poland
Prior art keywords
dgla
homo
linolenic acid
gamma linolenic
formulations containing
Prior art date
Application number
PL15728175T
Other languages
English (en)
Inventor
Giovanni Brotzu
Giuseppe BROTZU
Original Assignee
Fidia Farmaceutici S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia Farmaceutici S.P.A. filed Critical Fidia Farmaceutici S.P.A.
Publication of PL3145490T3 publication Critical patent/PL3145490T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361—Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A61K9/1272—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers with substantial amounts of non-phosphatidyl, i.e. non-acylglycerophosphate, surfactants as bilayer-forming substances, e.g. cationic lipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
PL15728175T 2014-05-06 2015-05-05 Liposomy zawierające kwas dihomo-gamma-linolenowy (dgla), zawierające je preparaty i ich zastosowanie PL3145490T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITCA20140003 2014-05-06
PCT/IB2015/053267 WO2015170247A1 (en) 2014-05-06 2015-05-05 Liposomes containing di-homo-gamma linolenic acid (dgla), formulations containing them and use thereof
EP15728175.9A EP3145490B1 (en) 2014-05-06 2015-05-05 Liposomes containing di-homo-gamma linolenic acid (dgla), formulations containing them and use thereof

Publications (1)

Publication Number Publication Date
PL3145490T3 true PL3145490T3 (pl) 2018-08-31

Family

ID=51136572

Family Applications (1)

Application Number Title Priority Date Filing Date
PL15728175T PL3145490T3 (pl) 2014-05-06 2015-05-05 Liposomy zawierające kwas dihomo-gamma-linolenowy (dgla), zawierające je preparaty i ich zastosowanie

Country Status (11)

Country Link
EP (1) EP3145490B1 (pl)
DK (1) DK3145490T3 (pl)
EA (1) EA029823B1 (pl)
ES (1) ES2673627T3 (pl)
HR (1) HRP20180866T1 (pl)
HU (1) HUE037543T2 (pl)
PL (1) PL3145490T3 (pl)
SA (1) SA516380231B1 (pl)
SI (1) SI3145490T1 (pl)
TR (1) TR201808036T4 (pl)
WO (1) WO2015170247A1 (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT201800005309A1 (it) * 2018-05-11 2019-11-11 Composizione ad attivita’ antimicrobica

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60120809A (ja) * 1983-11-30 1985-06-28 Akira Kitano 脱毛防止及び、養毛、発毛用シヤンプ−
EP0309086A1 (en) * 1987-09-07 1989-03-29 Efamol Holdings Plc Treatment of male pattern baldness and of unwanted hair growth
FR2711060B1 (fr) * 1993-10-13 1995-11-17 Oreal Procédé pour modifier la pousse des poils et/ou des cheveux et compositions utilisables à cet effet.
US5962015A (en) * 1997-05-02 1999-10-05 Kobo Products S.A.R.L. Stabilized liposomes
US8067470B2 (en) * 2008-02-01 2011-11-29 Mcdaniel William Robert Linoleic acid preparations for the topical treatment of male and female pattern androgenetic alopecia, age-related alopecia, and keratosis pilaris
IT1397867B1 (it) * 2010-02-03 2013-02-04 Brotzu Liposomi contenenti prostaglandina e1 (pge1), formulazioni che li contengono e loro uso
ITFI20120092A1 (it) * 2012-05-14 2013-11-15 Giovanni Brotzu Liposomi contenenti prostaglandina e1 (pge1) ed un estrogeno vegetale, formulazioni per uso topico che li contengono e loro uso.

Also Published As

Publication number Publication date
WO2015170247A1 (en) 2015-11-12
ES2673627T3 (es) 2018-06-25
EP3145490B1 (en) 2018-03-28
TR201808036T4 (tr) 2018-06-21
SA516380231B1 (ar) 2020-11-03
EA201650066A1 (ru) 2017-04-28
HUE037543T2 (hu) 2018-09-28
EP3145490A1 (en) 2017-03-29
HRP20180866T1 (hr) 2018-08-24
SI3145490T1 (sl) 2018-09-28
DK3145490T3 (en) 2018-06-25
EA029823B1 (ru) 2018-05-31

Similar Documents

Publication Publication Date Title
ZA201608209B (en) Stable cannabinoid formulations
IL252053A0 (en) Substituted pyrazolo(1,5-a)pyrimidines and their use in the treatment of medical disorders
GB201519088D0 (en) The use of bacteria formulations
EP3193888A4 (en) Novel formulations
EP3259032A4 (en) Improved descender
EP3132487A4 (en) Electrolyte formulations
EP3261443A4 (en) Desacetoxytubulysin h and analogs thereof
PL3157901T3 (pl) Preparaty, ich wytwarzanie i zastosowanie, oraz odpowiednie składniki
EP3191114A4 (en) Occidiofungin formulations and uses thereof
GB201421162D0 (en) Lanthanide complex formulations
EP3025705B8 (en) Stable ivabradine formulations
GB201419261D0 (en) Formulations
GB201419091D0 (en) Formulations
ZA201905379B (en) 1-amino-1-cyclopropanecaboxylic acid formulations
EP3139741A4 (en) Methods and compositions comprising 10-hydroxy-2-decenoic acid
RO130539B8 (ro) Compoziţie erbicidă, procedeu de preparare şi utilizarea acesteia
IL259073A (en) History of abscisic acid - converted at the 3' position
PL3253857T3 (pl) Preparaty wodne, ich wytwarzanie i zastosowanie
GB201518791D0 (en) Descender
HUE037543T2 (hu) Di-homo-gamma linolénsavat (DGLA) tartalmazó liposzómák, az azokat tartalmazó készítmények és alkalmazásuk
IL251656A0 (en) The compositions containing tiotropium, amino acid and acid and methods thereof
IL252955A0 (en) Compounds for mouthwash
HK1259196A1 (zh) 延遲釋放製劑、其製備方法和用途
ZA201703472B (en) Mouthrinse formulations
GB201709974D0 (en) Stable electrolyte formulations